Cargando…

Cancer: An unknown territory; rethinking before going ahead

Cancer is a disease of altered signaling and metabolism, causing uncontrolled division and survival of transformed cells. A host of molecules, factors, and conditions have been designated as underlying causes for the inception and progression of the disease. An enormous amount of data is available,...

Descripción completa

Detalles Bibliográficos
Autor principal: Upadhyay, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278524/
https://www.ncbi.nlm.nih.gov/pubmed/34291136
http://dx.doi.org/10.1016/j.gendis.2020.09.002
_version_ 1783722279304167424
author Upadhyay, Arun
author_facet Upadhyay, Arun
author_sort Upadhyay, Arun
collection PubMed
description Cancer is a disease of altered signaling and metabolism, causing uncontrolled division and survival of transformed cells. A host of molecules, factors, and conditions have been designated as underlying causes for the inception and progression of the disease. An enormous amount of data is available, system-wide interaction networks of the genes and proteins are generated over the years and have now reached up to a level of saturation, where we need to shift our focus to the more advanced and comprehensive methods and approaches of data analysis and visualization. Even with the availability of enormous literature on this one of the most pressing pathological conditions, a successful cure of the disease seems to be obscure. New treatment plans, like immunotherapy and precision medicine, are being employed for different studies. Nevertheless, their actual benefits to the patients would be known only after the evaluation of clinical data over the next few years. Therefore, we need to look at few fundamental challenges that should be addressed in more depth before we could devise better, rigorous, and comprehensive treatment plans and may successfully reach a possible cure of the disease. This article aims at bringing attention towards some fundamental gaps in our approach towards the disease that leads to failure in devising successful therapeutics.
format Online
Article
Text
id pubmed-8278524
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-82785242021-07-20 Cancer: An unknown territory; rethinking before going ahead Upadhyay, Arun Genes Dis Review Article Cancer is a disease of altered signaling and metabolism, causing uncontrolled division and survival of transformed cells. A host of molecules, factors, and conditions have been designated as underlying causes for the inception and progression of the disease. An enormous amount of data is available, system-wide interaction networks of the genes and proteins are generated over the years and have now reached up to a level of saturation, where we need to shift our focus to the more advanced and comprehensive methods and approaches of data analysis and visualization. Even with the availability of enormous literature on this one of the most pressing pathological conditions, a successful cure of the disease seems to be obscure. New treatment plans, like immunotherapy and precision medicine, are being employed for different studies. Nevertheless, their actual benefits to the patients would be known only after the evaluation of clinical data over the next few years. Therefore, we need to look at few fundamental challenges that should be addressed in more depth before we could devise better, rigorous, and comprehensive treatment plans and may successfully reach a possible cure of the disease. This article aims at bringing attention towards some fundamental gaps in our approach towards the disease that leads to failure in devising successful therapeutics. Chongqing Medical University 2020-09-18 /pmc/articles/PMC8278524/ /pubmed/34291136 http://dx.doi.org/10.1016/j.gendis.2020.09.002 Text en © 2020 Chongqing Medical University. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Upadhyay, Arun
Cancer: An unknown territory; rethinking before going ahead
title Cancer: An unknown territory; rethinking before going ahead
title_full Cancer: An unknown territory; rethinking before going ahead
title_fullStr Cancer: An unknown territory; rethinking before going ahead
title_full_unstemmed Cancer: An unknown territory; rethinking before going ahead
title_short Cancer: An unknown territory; rethinking before going ahead
title_sort cancer: an unknown territory; rethinking before going ahead
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278524/
https://www.ncbi.nlm.nih.gov/pubmed/34291136
http://dx.doi.org/10.1016/j.gendis.2020.09.002
work_keys_str_mv AT upadhyayarun canceranunknownterritoryrethinkingbeforegoingahead